Bruce Guthrie, GP and Professor of Primary Care Medicine at the University of Dundee Medical School shares his experiences of caring for patients with multimorbidity
Dr Benett discusses how becoming a NICE guidance team member helped him to find new ways to treat his patient with kidney disease
NICE does not recommend breast cancer drug palbociclib (Ibrance, Pfizer) because its cost is too high in relation to its potential benefits in draft guidance out for consultation.
NICE has advised health and care professionals to talk to older people about falls.
NICE publishes first guideline on cerebral palsy
NICE has set out its position on its complex but positive relationship with the life sciences industry.
Plans for NICE to recover the costs of its appraisals of drugs, medical devices and diagnostics, through charges to the companies which make them, have been put on hold until the Government completes its life sciences strategy.
Patients with advanced kidney cancer will have routine NHS access to the drug everolimus following recommendations by NICE, rather than apply to the Cancer Drugs Fund (CDF).
Experts acknowledge that mental health problems may be more difficult to diagnose for people with learning disabilities. This is because it can be harder for the person to explain how they are feeling and what help they would like.
Patients’ priorities will be brought to the fore in new Alzheimer’s project
Care home residents should be helped to brush their teeth twice a day, says NICE
At this time of year we like to stop and reflect on some of the news we’ve shared with you over the past twelve months…
The drug, sorafenib (also known as Nexavar), which is used for treating advanced hepatocellular carcinoma, is not value for money, NICE has said in new draft guidance.
Deirdre and Emily both care for terminally-ill children. They tell us why it is so important for their final wishes to be heard.
Kadcyla (also called trastuzumab emtansine and made by Roche) is currently being funded through the Cancer Drugs Fund. NICE is looking again at its 2015 guidance on the drug to see whether it should be funded routinely on the NHS.
NICE has issued draft guidance setting out what medicines adults, young people and children with asthma should take to control symptoms and reduce asthma attacks.
Due to a technical fault, the December content updates to the NICE BNF and BNFC apps have been delayed until early February 2017.
Luke highlights the issues people with co-occurring mental illness and substance use face when they try to seek help.
Karen tells us why and how we all strive for normality in the face of death.
People who drink too much should be sent for scans to detect early liver disease, says NICE
Social care providers should also ensure oral health is included in care plans for people receiving support, says NICE
Dr Gill Davies urges parents and carers to help children look after their baby teeth.
Jakki tells us what she hopes the new 'Management of coexisting severe mental illness and substance misuse' guidance will achieve.
Traditional under the tongue or armpit temperature-taking are among the recommended ways of monitoring a patient’s temperature to help avoid hypothermia during surgery, says NICE.
NICE Scientific Advice participates in FDA payer programme for medtech industry
Stephen and Paul both provide spiritual care for dying children and their families. For many people the word ‘spiritual’ is read with religious connotations. They tell us why they are pleased the new NICE ‘End of life care for children’ guidance broadens this definition…
Mark tells us about the problems he and his neighbours have experienced with air pollution.
Jan and Jo talk about how working with the charity, Together for Short Lives, enabled young people to make a valuable contribution to the NICE guideline ‘End of life care for children’.
Victoria talks about plans to improve how NICE works with members of the public.
Some older people should be sent to dance groups or choirs to help maintain their health, says NICE
Dr Sotiris Vardoulakis discusses the importance of NICE's new draft guidance on air pollution.
Hundreds of people with advanced lung cancer will now have access to new drug pembrolizumab, also known as Keytruda, after NICE recommends it for routine NHS use.
NICE recommends lorry and bus drivers drive ‘smoothly’ to help reduce harmful air pollution linked to 25,000 deaths a year in new draft guidance.
Adults with severe asthma now have access to new drug mepolizumab, also known as Nucala, after NICE recommends it for NHS use.
HIV testing should be offered in A&Es and GP practices depending on local HIV prevalence, says NICE and PHE in new guidance
NICE’s updated guideline on low back pain and sciatica recommends exercise in all its forms - for example stretching, strengthening, aerobics or yoga - as the first step in managing the condition.
People at risk of fractures due to osteoporosis should be considered for medication, Nice says.
NICE has published new guidance for the management of coexisting severe mental illness and substance misuse - often termed 'dual diagnosis'.
Women with a family history of breast cancer should be offered anastrozole, not tamoxifen, says NICE in draft guidance
Hundreds of people could benefit as NICE decision means ibrutinib can come off the Cancer Drugs Fund (CDF) and be routinely available to treat chronic lymphocytic leukaemia.
Martin Cowie, Professor of Cardiology & Honorary Consultant Cardiologist, shares his thoughts on becoming a new Non-Executive Director on the NICE Board
NICE has published final guidance recommending dapagliflozin for treating type 2 diabetes in ‘triple therapy’
Hundreds of patients set to benefit after NICE draft guidance recommends pomalidomide, a drug that treats some people with bone marrow cancer, for routine use on the NHS.
Sign-up for updates on the latest information published by the NICE medicines and prescribing team. Includes: new evidence summaries medicines and prescribing guidance news and updates relating to medicines.
Fewer antibiotics are being prescribed by doctors in England for the first time, new data shows.
Five new Non-Executive Directors have been appointed to the Board of NICE
Sign-up for monthly updates on the most important guidance and advice relating to prescribing and medicines optimisation. Includes information from key national bodies including NICE, SIGN and the MHRA.
NICE approves the third breast cancer drug is as many weeks as pertuzumab is recommended to shrink tumours in some people with breast cancer so surgery can take place.
More than 75% of treatments in the Cancer Drugs Fund (CDF) which have been looked at again by NICE have received positive recommendations for routine NHS use.
The drug pegylated liposomal irinotecan, was not clinically effective enough to justify its high cost, NICE says in draft guidance.